The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Biological Gene Delivery Vehicles: Beyond Viral Vectors
Open accessAbstract
Gene therapy covers a broad spectrum of applications, from gene replacement and knockdown for genetic or acquired diseases such as cancer, to vaccination, each with different requirements for gene delivery. Viral vectors and synthetic liposomes have emerged as the vehicles of choice for many applications today, but both have limitations and risks, including complexity of production, limited packaging capacity, and unfavorable immunological features, which restrict gene therapy applications and hold back the potential for preventive gene therapy. While continuing to improve these vectors, it is important to investigate other options, particularly nonviral biological agents which include bacteria, bacteriophage, virus-like particles (VLPs), erythrocyte ghosts, and exosomes. Exploiting the natural properties of these biological entities for specific gene delivery applications will expand the repertoire of gene therapy vectors available for clinical use. Here, we review the prospects for nonviral biological delivery vehicles as gene therapy agents with focus on their unique evolved biological properties and respective limitations and potential applications. The potential of these nonviral biological entities to act as clinical gene therapy delivery vehicles has already been shown in clinical trials using bacteria-mediated gene transfer and with sufficient development, these entities will complement the established delivery techniques for gene therapy applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., & Henson, P. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2207 · Cited by 3,316
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?
Lutz, M. B., & Schuler, G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02281-0 · Cited by 1,349
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
Artis, D. (2008) · Nature reviews. Immunology · doi:10.1038/nri2316 · Cited by 1,136
Tlaskalová-Hogenová, H., Štěpánková, R., Hudcovic, T., Tučková, L., Cukrowska, B., Lodinová-Žádnı́ková, R., Kozáková, H., Rossmann, P., Bártová, J., Sokol, D., et al. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.02.005 · Cited by 755
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614
Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (1997) · PubMed · Cited by 527
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Kawabata, K., Takakura, Y., & Hashida, M. (1995) · Pharmaceutical Research · doi:10.1023/a:1016248701505 · Cited by 456
Yu, Y. A., Shabahang, S., Timiryasova, T. M., Zhang, Q., Beltz, R., Gentschev, I., Goebel, W., & Szalay, A. A. (2004) · Nature Biotechnology · doi:10.1038/nbt937 · Cited by 423
Kim, S.-H., Lechman, E. R., Bianco, N., Menon, R., Keravala, A., Nash, J., Mi, Z., Watkins, S. C., Gambotto, A., & Robbins, P. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6440 · Cited by 380
Silencing and Variegation of Gammaretrovirus and Lentivirus Vectors
Ellis, J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1241 · Cited by 379
Bacteria-mediated delivery of nanoparticles and cargo into cells
Akin, D., Sturgis, J., Ragheb, K., Sherman, D., Burkholder, K., Robinson, J. P., Bhunia, A. K., Mohammed, S., & Bashir, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.149 · Cited by 347
Nemunaitis, J., Cunningham, C., Senzer, N., Kuhn, J., Cramm, J., Litz, C., Cavagnolo, R., Cahill, A., Clairmont, C., & Sznol, M. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700634 · Cited by 341
Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles
Birmingham, C. L., Canadien, V., Kaniuk, N. A., Steinberg, B. E., Higgins, D. E., & Brumell, J. H. (2008) · Nature · doi:10.1038/nature06479 · Cited by 330
Jiang, H., Couto, L. B., Patarroyo-White, S., Liu, T., Nagy, D., Vargas, J. A., Zhou, S., Scallan, C. D., Sommer, J., Vijay, S., et al. (2006) · Blood · doi:10.1182/blood-2006-04-017913 · Cited by 330
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Hyde, S. C., Pringle, I. A., Abdullah, S., Lawton, A. E., Davies, L. A., Varathalingam, A., Nunez-Alonso, G., Green, A.-M., Bazzani, R. P., Sumner-Jones, S. G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1399 · Cited by 310
Biologic properties and enucleation of red blood cells from human embryonic stem cells
Lu, S.-J., Feng, Q., Park, J. S., Vida, L., Lee, B.-S., Strausbauch, M., Wettstein, P. J., Honig, G. R., & Lanza, R. (2008) · Blood · doi:10.1182/blood-2008-05-157198 · Cited by 293
Short hairpin RNA–expressing bacteria elicit RNA interference in mammals
Xiang, S., Fruehauf, J., & Li, C. J. (2006) · Nature Biotechnology · doi:10.1038/nbt1211 · Cited by 271
Exosomal transfer of proteins and RNAs at synapses in the nervous system
Smalheiser, N. R. (2007) · Biology Direct · doi:10.1186/1745-6150-2-35 · Cited by 251
Transdermal protein delivery by a coadministered peptide identified via phage display
Chen, Y., Shen, Y., Guo, X., Zhang, C., Yang, W., Ma, M., Liu, S., Zhang, M., & Wen, L.-P. (2006) · Nature Biotechnology · doi:10.1038/nbt1193 · Cited by 249
Nanoparticles for the delivery of genes and drugs to human hepatocytes
Yamada, T., Iwasaki, Y., Tada, H., Iwabuki, H., Chuah, M. K., VandenDriessche, T., Fukuda, H., Kondo, A., Ueda, M., Seno, M., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt843 · Cited by 247
Shoji, I., Miyamura, T., Aizaki, H., Tani, H., Matsuura, Y., Ishii, K., Chiba, T., & Saito, I. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-10-2657 · Cited by 245
Zhao, M., Geller, J., Ma, H., Yang, M., Penman, S., & Hoffman, R. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703867104 · Cited by 244
Hartman, Z. C., Appledorn, D. M., & Amalfitano, A. (2008) · Virus Research · doi:10.1016/j.virusres.2007.10.005 · Cited by 239
Functional gene transfer from intracellular bacteria to mammalian cells
Grillot-Courvalin, C., Goussard, S., Huetz, F., Ojcius, D. M., & Courvalin, P. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-862 · Cited by 230
Abe, T., Takahashi, H., Hamazaki, H., Miyano-Kurosaki, N., Matsuura, Y., & Takaku, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1133 · Cited by 229
Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseases
Ochs, H. D., Davis, S. D., & Wedgwood, R. J. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106756 · Cited by 219
Wang, Z., Kuhr, C. S., Allen, J. M., Blankinship, M., Gregorevic, P., Chamberlain, J. S., Tapscott, S. J., & Storb, R. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300161 · Cited by 218
Hee Kim, S., Bianco, N., Menon, R., Lechman, E. R., Shufesky, W. J., Morelli, A. E., & Robbins, P. D. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.015 · Cited by 217
Immune Responses to Adeno-Associated Virus Vectors
Zaiss, A., & Muruve, D. (2005) · Current Gene Therapy · doi:10.2174/1566523054065039 · Cited by 213
Latest development in viral vectors for gene therapy
Lundstrom, K. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(02)00042-2 · Cited by 212
Stubbs, A. C., Martin, K. S., Coeshott, C., Skaates, S. V., Kuritzkes, D. R., Bellgrau, D., Franzusoff, A., Duke, R. C., & Wilson, C. C. (2001) · Nature Medicine · doi:10.1038/87974 · Cited by 208
Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity
ZHANG, J., LIU, F., & HUANG, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.004 · Cited by 195
Rivière, C., Danos, O., & Douar, A. M. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302766 · Cited by 192
Fate of Bacteriophage Lambda in Non-immune Germ-free Mice
GEIER, M. R., TRIGG, M. E., & MERRIL, C. R. (1973) · Nature · doi:10.1038/246221a0 · Cited by 191
Chen, X. S., Casini, G., Harrison, S. C., & Garcea, R. L. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4464 · Cited by 185
Rotavirus virus-like particles administered mucosally induce protective immunity
O'Neal, C. M., Crawford, S. E., Estes, M. K., & Conner, M. E. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8707-8717.1997 · Cited by 183
Accelerated clearance of a second injection of PEGylated liposomes in mice
Ishida, T., Masuda, K., Ichikawa, T., Ichihara, M., Irimura, K., & Kiwada, H. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00085-1 · Cited by 183
Escherichia coli‐based cell‐free synthesis of virus‐like particles
Bundy, B. C., Franciszkowicz, M. J., & Swartz, J. R. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21716 · Cited by 179
Towards the preparative and large-scale precision manufacture of virus-like particles
Pattenden, L. K., Middelberg, A. P. J., Niebert, M., & Lipin, D. I. (2005) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.07.011 · Cited by 177
Silencing of gene expression: implications for design of retrovirus vectors
Pannell, D., & Ellis, J. (2001) · Reviews in Medical Virology · doi:10.1002/rmv.316 · Cited by 174
Sedlik, C., Saron, M.-F., Sarraseca, J., Casal, I., & Leclerc, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7503 · Cited by 168
Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle
Jepson, C. D., & March, J. B. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.065 · Cited by 167
Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector
Sarkis, C., Serguera, C., Petres, S., Buchet, D., Ridet, J.-L., Edelman, L., & Mallet, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260472897 · Cited by 163
Lowenstein, P. R., Mandel, R. J., Xiong, W.-D., Kroeger, K. M., & Castro, M. G. (2007) · Current Gene Therapy · doi:10.2174/156652307782151498 · Cited by 157
Hofmann, C., & Strauss, M. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300607 · Cited by 156
In vitro gene transfer using human papillomavirus-like particles
Touzé, A. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.5.1317 · Cited by 148
Targeted gene delivery to mammalian cells by filamentous bacteriophage
Poul, M., & Marks, J. D. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2678 · Cited by 145
Innate immune response induced by gene delivery vectors
Sakurai, H., Kawabata, K., Sakurai, F., Nakagawa, S., & Mizuguchi, H. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.012 · Cited by 144
AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa
Smith, A. J., Schlichtenbrede, F. C., Tschernutter, M., Bainbridge, J. W., Thrasher, A. J., & Ali, R. R. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00144-8 · Cited by 141
The state of the art of adeno-associated virus-based vectors in gene therapy
Coura, R., & Nardi, N. B. (2007) · Virology Journal · doi:10.1186/1743-422x-4-99 · Cited by 135
Baculovirus Stimulates Antiviral Effects in Mammalian Cells
Gronowski, A. M., Hilbert, D. M., Sheehan, K. C. F., Garotta, G., & Schreiber, R. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9944-9951.1999 · Cited by 135
Erythrocyte engineering for drug delivery and targeting
Magnani, M., Rossi, L., D’Ascenzo, M., Panzani, I., Bigi, L., & Zanella, A. (1998) · Biotechnology and Applied Biochemistry · doi:10.1111/j.1470-8744.1998.tb00505.x · Cited by 130
Via, S. T., zu Altenschildesche, G. M., & Doerfler, W. (1983) · Virology · doi:10.1016/0042-6822(83)90067-3 · Cited by 122
Hüser, A., Rudolph, M., & Hofmann, C. (2001) · Nature Biotechnology · doi:10.1038/88122 · Cited by 118
Targeting Bacteriophage to Mammalian Cell Surface Receptors for Gene Delivery
LaRocca, D., Witte, A., Johnson, W., Pierce, G. F., & Baird, A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.16-2393 · Cited by 116
Vanderlinde, E. S., Heal, J. M., & Blumberg, N. (2002) · BMJ · doi:10.1136/bmj.324.7340.772 · Cited by 112
The role of CpG motifs in immunostimulation and gene therapy
Scheule, R. K. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00090-9 · Cited by 109
Takamura, S., Niikura, M., Li, T.-C., Takeda, N., Kusagawa, S., Takebe, Y., Miyamura, T., & Yasutomi, Y. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302193 · Cited by 99
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides
Magnani, M., Rossi, L., Fraternale, A., Bianchi, M., Antonelli, A., Crinelli, R., & Chiarantini, L. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301758 · Cited by 98
Lufino, M. M., Edser, P. A. H., & Wade‐Martins, R. (2008) · Molecular Therapy · doi:10.1038/mt.2008.156 · Cited by 97
AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects
Hasbrouck, N. C., & High, K. A. (2008) · Gene Therapy · doi:10.1038/gt.2008.71 · Cited by 95
Magnani, M., Rossi, L., Brandi, G., Schiavano, G. F., Montroni, M., & Piedimonte, G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6477 · Cited by 95
Brüssow, H., Frémont, M., Bruttin, A., Sidoti, J., Constable, A., & Fryder, V. (1994) · Applied and Environmental Microbiology · doi:10.1128/aem.60.12.4537-4543.1994 · Cited by 92
Potential of AAV vectors in the treatment of metabolic disease
Alexander, I. E., Cunningham, S. C., Logan, G. J., & Christodoulou, J. (2008) · Gene Therapy · doi:10.1038/gt.2008.64 · Cited by 90
Delivery of antisense oligonucleotides to leukemia cells by RNA bacteriophage capsids
Wu, M., Sherwin, T., Brown, W. L., & Stockley, P. G. (2005) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2004.11.011 · Cited by 86
Taylor, N. N., Uribe, L., Smith, S. M., Jahn, T., Kohn, D. B., & Weinberg, K. I. (1996) · Blood · doi:10.1182/blood.v87.8.3103.bloodjournal8783103 · Cited by 83
Development of PEGylated adenovirus vector with targeting ligand
Eto, Y., Yoshioka, Y., Mukai, Y., Okada, N., & Nakagawa, S. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.025 · Cited by 80
Receptor-Targeted Gene Delivery Using Multivalent Phagemid Particles
LaRocca, D., Jensen-Pergakes, K., Burg, M. A., & Baird, A. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0284 · Cited by 80
HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae
Sakuragi, S., Goto, T., Sano, K., & Morikawa, Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082281199 · Cited by 77
Integration Site Selection by Retroviral Vectors: Molecular Mechanism and Clinical Consequences
Daniel, R., & Smith, J. A. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.148 · Cited by 74
Non‐immunostimulatory nonviral vectors
Liu, F., Shollenberger, L. M., & Huang, L. (2004) · The FASEB Journal · doi:10.1096/fj.04-2187fje · Cited by 70
Bacteriophage lambda as a cloning vector
Chauthaiwale, V. M., Therwath, A., & Deshpande, V. (1992) · Microbiological Reviews · doi:10.1128/mr.56.4.577-591.1992 · Cited by 67
Sellins, K. S., Fradkin, L. G., Liggitt, D., & DOW, S. W. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.008 · Cited by 64
Engineered E. coli delivers therapeutic genes to the colonic mucosa
Castagliuolo, I., Beggiao, E., Brun, P., Barzon, L., Goussard, S., Manganelli, R., Grillot‐Courvalin, C., & Palù, G. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302493 · Cited by 62
In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells
Chatel, J., Pothelune, L., Ah-Leung, S., Corthier, G., Wal, J. M., & Langella, P. (2008) · Gene Therapy · doi:10.1038/gt.2008.59 · Cited by 60
In vivo clearance of antibody-sensitized human drug carrier erythrocytes
Eichler, H. G., Gasic, S., Bauer, K., Korn, A., & Bacher, S. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.180 · Cited by 58
Reynaud, A., Cloastre, L., Bernard, J., Laveran, H., Ackermann, H., Licois, D., & Joly, B. (1992) · Veterinary Microbiology · doi:10.1016/0378-1135(92)90114-9 · Cited by 55
Development of gene drug delivery systems based on pharmacokinetic studies
Takakura, Y., Nishikawa, M., Yamashita, F., & Hashida, M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00209-8 · Cited by 53
Transfusion transmitted virus: A review on its molecular characteristics and role in medicine
Irshad, M., Yk, J., Sharma, Y., & Dhar, I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i32.5122 · Cited by 48
Shearer, W. T., Lugg, D. J., Rosenblatt, H. M., Nickolls, P. M., Sharp, R., Reuben, J. M., & Ochs, H. D. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.112269 · Cited by 47
Kitajima, M., Abe, T., Miyano‐Kurosaki, N., Taniguchi, M., Nakayama, T., & Takaku, H. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300364 · Cited by 46
Magnani, M., Casabianca, A., Fraternale, A., Brandi, G., Gessani, S., Williams, R. J., Giovine, M., Damonte, G., FLORA, A. D., & Benatti, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4403 · Cited by 46
Abdul‐Wahid, A., & Faubert, G. M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.012 · Cited by 42
Prodrug converting enzyme gene delivery by L. monocytogenes
Stritzker, J., Pilgrim, S., Szalay, A. A., & Goebel, W. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-94 · Cited by 41
Enhanced phagemid particle gene transfer in camptothecin-treated carcinoma cells.
Burg, M. A., Jensen-Pergakes, K., Gonzalez, A. M., Ravey, P., Baird, A., & Larocca, D. (2002) · PubMed · Cited by 41
Bacterial delivery of functional messenger RNA to mammalian cells
Schoen, C. U., Kolb‐Mäurer, A., Geginat, G., Löffler, D., Bergmann, B., Stritzker, J., Szalay, A. A., Pilgrim, S., & Goebel, W. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00507.x · Cited by 40
Piersanti, S., Cherubini, G., Martina, Y., Salone, B., Avitabile, D., Grosso, F., Cundari, E., Zenzo, G. D., & Saggio, I. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0543-2 · Cited by 40
Hofmann, C., Hüser, A., Lehnert, W., & Strauss, M. (1999) · Biological Chemistry · doi:10.1515/bc.1999.052 · Cited by 39
Cell targeted phagemid rescued by preselected landscape phage
Mount, J. D., Samoylova, T. I., Morrison, N. E., Cox, N. R., Baker, H. J., & Petrenko, V. A. (2004) · Gene · doi:10.1016/j.gene.2004.07.006 · Cited by 38
Erythrocyte ghost-mediated gene delivery for prolonged and blood-targeted expression
Byun, H., Suh, D., Yoon, H. S., Kim, J., Choi, H.-G., Kim, W., Ko, J., & Oh, Y. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302180 · Cited by 36
Inhibition of Macrophage iNOS by Selective Targeting of Antisense PNA
Chiarantini, L., Cerasi, A., Fraternale, A., Andreoni, F., Scarfı̀, S., Giovine, M., Clavarino, E., & Magnani, M. (2002) · Biochemistry · doi:10.1021/bi020079f · Cited by 32
Hamaji, Y., FUJIMORI, M., Sasaki, T., Matsuhashi, H., MATSUI-SEKI, K., Shimatani, Y., Kano, Y., Amano, J., & Taniguchi, S. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60502 · Cited by 31
RAC Reviews Serious Adverse Event Associated with AAV Therapy Trial
Williams, D. A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300352 · Cited by 26
A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patients
Lucidi, V., Tozzi, A. E., Bella, S., & Turchetta, A. (2006) · BMC Pediatrics · doi:10.1186/1471-2431-6-17 · Cited by 22
Folate Conjugated Doxorubicin-Loaded Membrane Vesicles for Improved Cancer Therapy
Mishra, P. R., & Jain, N. K. (2003) · Drug Delivery · doi:10.1080/714044320 · Cited by 22
Celec, P., Gardlík, R., Pálffy, R., Hodosy, J., Stuchlík, S., Drahovská, H., Stuchlíková, M., Minárik, G., Lukács, J., Jurkovičová, I., et al. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.07.039 · Cited by 18
Shen, H., Kanoh, M., Liu, F., Maruyama, S., & Asano, Y. (2004) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2004.tb03514.x · Cited by 17
Zelmer, A., Krusch, S., Koschinski, A., Rohde, M., Repp, H., Chakraborty, T., & Weiß, S. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.764 · Cited by 15
Li, J. Z., Li, H., Hankins, G. R., Dunford, B., & Helm, G. A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302502 · Cited by 8
Cited by
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Self-citationBio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Exosomes: Therapy delivery tools and biomarkers of diseases
Barile, L., & Vassalli, G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.020 · Cited by 1,038
Non Viral Vectors in Gene Therapy- An Overview
Ramamoorth, M. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/10443.5394 · Cited by 761
Metadata
- Authors
- Seow, Y., & Wood, M. J.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 17
- Issue
- 5
- Pages
- 767-777
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2153138904
- Cited by
- 327
- References
- 104
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.